San Diego, CA, United States of America

Henri Sasmor

This inventor holds 1 USPTO granted patent. Top assignee: Ligand Pharmaceuticals, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henri Sasmor. Retrieved from https://idiyas.com/inventor/henri-sasmor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Henri Sasmor

Introduction

Henri Sasmor is a notable inventor based in San Diego, California. He has made significant contributions to the field of crystallization, particularly through his innovative methods and formulations. His work has implications in various scientific and industrial applications.

Latest Patents

Henri Sasmor holds a patent for "Crystalline forms and methods of producing crystalline forms of a compound." This patent discloses methods for crystallizing a specific compound, referred to as Formula (I). The crystalline forms disclosed in the patent include crystalline Form C, crystalline Form E, and crystalline Form B. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Sasmor is currently employed at Ligand Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions in the pharmaceutical industry, contributing to the development of new therapeutic compounds.

Collaborations

Henri collaborates with Lin Zhi, a fellow researcher, to further enhance their work in crystallization and compound development. Their partnership exemplifies the importance of teamwork in achieving groundbreaking results in scientific research.

Conclusion

Henri Sasmor's contributions to the field of crystallization and his innovative patent highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence advancements in the development of new compounds and methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…